UNSPSC 51161500: Antiasthmatic drugs

This classification denotes bronchial disorder with three distinct components: airway hyper-responsiveness, airway inflammation, and intermittent airway obstruction, the disease called asthma. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspneabronchial disorder with three distinct components: airway hyper-responsiveness (respiratory hypersensitivity), airway inflammation, and intermittent airway obstruction. it is characterized by spasmodic contraction of airway smooth muscle, wheezing, and dyspnea.

UNSPSC 51161500 Antiasthmatic drugs is a Class code covering pharmaceutical products for the treatment and management of asthma, including bronchodilators, corticosteroids, and combination inhalers that state and local health agencies, school districts, and public hospitals procure for patient care, emergency response, and medication stock replenishment. State and local governments purchase antiasthmatic medications through established pharmaceutical supply contracts, group purchasing organizations, and direct procurement from licensed distributors and manufacturers to support public health clinics, emergency medical services, school health offices, and institutional care settings.

The source provided contains no recent state and local contract opportunities tagged to this code, so current market activity cannot be characterized by issuing body, geographic spread, or representative solicitations. The absence of posted opportunities under this Class code may reflect that antiasthmatic drug procurement often flows through standing master service agreements, cooperative purchasing vehicles, or direct vendor-managed inventory arrangements rather than individual RFPs, RFQs, or ITBs.